Trial intelligence / Profile preview

FSH versus FSH plus growth hormone for ovulation stimulation in IUI candidates

IRCT20230512058157N1Phase 3Completed

Sponsor
Urmia University of Medical Sciences
Start
Jun 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of follitropin and somatropin in infertility (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Ovulation stimulation response and Pregnancy outcomes. Started Jun 2023; status: completed.

02

Drugs

follitropinsomatropin
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT20230512058157N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230512058157N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call